Is this you? Create Your Porfile
Avatar

Wolfgang Mueller

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Wolfgang Mueller is active.

Explore More

Publication

Featured researches published by Wolfgang Mueller.

Biochemical Pharmacology | 2005

The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway

Laureano de la Vega; Eduardo Muñoz; Marco A. Calzado; Klaus Lieb; Eduardo Candelario-Jalil; Harald Gschaidmeir; Lothar Färber; Wolfgang Mueller; Thomas Stratz; Bernd L. Fiebich

Nature Reviews Rheumatology | 2008

5-HT3 receptor antagonist for the treatment of tendinopathy

Kazem Mousavizadeh; Thomas Stratz; Wolfgang Mueller; Bernd L. Fiebich

Archive | 2002

Treatment of non-pathogen induced skin diseases, e.g. chronic eczema, neurodermatitis, psoriasis, urticaria or burns, by blockade of the 5HT-3 receptor, e.g. using tropisetron

Thomas Stratz; Wolfgang Mueller; James P Harnisch

Archive | 2009

Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia

Lothar Färber; Wolfgang Mueller; Thomas Stratz

Archive | 2002

Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases

Wolfgang Mueller; Thomas Stratz; Lothar Faerber

Archive | 2000

Verwendung von antagonisten der 5-ht3-rezeptoren zur behandlung von muskuloeskeletalen erkrankungen Use of antagonists of 5-HT3 receptors for the treatment of diseases muskuloeskeletalen

Wolfgang Mueller; Thomas Stratz; Lothar Faerber

Archive | 1999

Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome

Wolfgang Mueller; Thomas Stratz; Lothar Färber

Archive | 1999

Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia

Wolfgang Mueller; Thomas Stratz; Lothar Faerber

Archive | 1999

Utilisations d'antagonistes de substance p pour le traitement du syndrome de la fatigue chronique et/ou de la fibromyalgie et utilisation des antagnistes du recepteur nk-1 pour letraitement du syndrome de la fatigue chronique

Lothar Färber; Wolfgang Mueller; Thomas Stratz

Archive | 1999

Verwendung von substanz p antagonisten zur behandlung des chronischen ermüdungssyndroms und/oder der fibromyalgie Use of substance P antagonists for the treatment of chronic fatigue syndrome and / or fibromyalgia

Wolfgang Mueller; Thomas Stratz; Lothar Faerber

Explore More

Collaboration

Dive into the Wolfgang Mueller's collaboration.

Top Co-Authors
Avatar

Thomas Stratz

Novartis

View shared research outputs
Top Co-Authors
Avatar

Lothar Färber

Novartis

View shared research outputs
Top Co-Authors
Avatar

Lothar Faerber

Novartis

View shared research outputs
Top Co-Authors
Avatar

Bernd L. Fiebich

University of Freiburg

View shared research outputs
Top Co-Authors
Avatar

Harald Gschaidmeir

Novartis

View shared research outputs
Top Co-Authors
Avatar

Eduardo Candelario-Jalil

University of Freiburg

View shared research outputs
Top Co-Authors
Avatar

Klaus Lieb

University of Freiburg

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge